1.27 N/A 0.58% 0.00% Distribution costs (41.75 ) (24.14 ) (17.61 ) 72.95% (19.11%) (13.74%) Administrative expenses (95.74 ) (94.34 ) (1.40 ) 1.48% (43.82%) (53.71%) Other Expenses Impairment loss of
-27.5% -24.5% 2,120.4 1,782.4 -15.9% Other income 31.8 15.9 22.9 -28.1% +44.1% 51.7 38.7 -25.1% Selling and distribution expenses 587.2 536.7 463.7 -21.0% -13.6% 1,175.1 1,000.4 -14.9% Administrative
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
trustee, under Clause 20; (13) the trust’s disclosure of information, under Clause 21; (14) the distribution to the unit holders, under Clause 22; (15) the proposal for resolution and the general meeting of
that the issuer of securities implements the good corporate governance and sound management and operations which ensure accountability to its shareholders; (5) to enquire about the assumptions and the
ตามที่คณะกรรมการ ก.ล.ต. มีมติเห็นชอบการปรับปรุงหลักเกณฑ์เกี่ยวกับการบริหารกิจการ (governance) ของผู้ประกอบธุรกิจสินทรัพย์ดิจิทัล รวมทั้งการปรับปรุงหลักเกณฑ์เกี่ยวกับ Exchange rules โดย ก.ล.ต. ได้
focus on corporate governance assessment. We provide guidelines on increasing the proportion of women on boards and issuing anti-discrimination policies. This is in line with SET's vision "To Make the